Author:
Fischer Tanja C.,Bester Carolin,Ohle Marc,Kloft Beatrix,Welker Pia,Quarcoo David
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health
Reference42 articles.
1. Adamou JE, Aiyar N, Van Horn S et al., (1995). Cloning and functional characterization of the human vasoactive intestinal peptide (VIP)-2 receptor. Biochem Biophys Res Cummun 385–92
2. Akimoto S, Ishikawa O, Igarashi Y et al., (1998). Dermal mast cells in scleroderma: their skin density, tryptase/chymase phenotypes and degranulation. Br J Dermatol. 138(3):399–406
3. Bennett LA, Johnson JM, Stephens DP et al., (2003). Evidence for a role for vasoactive intestinal peptide in active vasodilatation in the cutaneous vasculature of humans. J Physiol. 552(Pt 1):223–32
4. Bellinger DL, Lorton D, Brouxhon S et al., (1996). The significance of vasoactive intestinal polypeptide (VIP) in immunomodulation. Adv Neuroimmunol.;6(1):5–27.
5. Berisha H, Foda H, Sakakibara H et al., (1990). Vasoactive intestinal peptide prevents lung injury due to xanthine/xanthine oxidase. Am J Physiol. 1990 Aug;259(2 Pt 1):L151–5.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献